Published in Urol Res on October 29, 1975
The standardization of terminology of lower urinary tract function. J Urol (1979) 2.82
Cellular origin and differentiation of renal carcinomas. A fluorescence microscopic study with kidney-specific antibodies, antiintermediate filament antibodies, and lectins. Lab Invest (1983) 1.82
Primary evaluation of patients suspected of having interstitial cystitis (IC). Eur Urol (2004) 1.46
Lectins as fluorescence microscopic markers for saccharides in the human kidney. Lab Invest (1981) 1.45
Comparison of primary orchiectomy and polyoestradiol phosphate in the treatment of advanced prostatic cancer. Finnprostate Group. Br J Urol (1990) 1.41
Prostatic tissue pressure measurement as a possible diagnostic procedure in patients with chronic nonbacterial prostatitis/chronic pelvic pain syndrome. Urol Res (2000) 1.37
Eosinophil cationic protein (ECP): molecular and biological properties and the use of ECP as a marker of eosinophil activation in disease. Clin Exp Allergy (1999) 1.28
Source attribution of human campylobacteriosis using a meta-analysis of case-control studies of sporadic infections. Epidemiol Infect (2012) 1.26
"Epidemic" of acute urethral stricture after open-heart surgery. Lancet (1982) 1.20
Alternating mitomycin C and bacillus Calmette-Guerin instillation prophylaxis for recurrent papillary (stages Ta to T1) superficial bladder cancer. Finnbladder Group. J Urol (1996) 1.19
Carcinoma in situ of contralateral testis in patients with testicular germ cell cancer: study of 27 cases in 500 patients. Br Med J (Clin Res Ed) (1986) 1.15
Smooth muscle antibodies of actin and "non-actin" specificity. Clin Immunol Immunopathol (1978) 1.09
Unexpected urethral strictures after short-term catheterization in open-heart surgery. Scand J Urol Nephrol (1984) 1.08
Pelvic floor exercise versus surgery for female urinary stress incontinence. Urol Int (1986) 1.06
Histamine content and mast cell count of detrusor muscle in patients with interstitial cystitis and other types of chronic cystitis. Br J Urol (1983) 1.06
High flow infravesical obstruction in men: symptomatology, urodynamics and the results of surgery. J Urol (1982) 1.05
Urinary catheter structure and testing methods in relation to tissue toxicity. Br J Urol (1986) 1.04
Non-cholinergic, non-adrenergic nerve mediated relaxation of trigone, bladder neck and urethral smooth muscle in vitro. J Urol (1983) 1.01
World Health Organization Consensus Committee recommendations concerning the diagnosis of BPH. Prog Urol (1991) 1.01
Improvement of pressure flow parameters with finasteride is greater in men with large prostates. Finasteride Urodynamics Study Group. J Urol (1999) 1.01
Permeability and ultrastructure of human bladder epithelium. Br J Urol (1983) 1.00
Complications of Bacillus Calmette-Guerin immunotherapy: review of 2602 patients and comparison of chemotherapy complications. Prog Clin Biol Res (1989) 0.99
The functional heterogeneity of eosinophil cationic protein is determined by a gene polymorphism and post-translational modifications. Clin Exp Allergy (2007) 0.94
Late metastases of renal cell carcinoma to the thyroid gland. Ann Chir Gynaecol Fenn (1969) 0.93
Source attribution of human salmonellosis using a meta-analysis of case-control studies of sporadic infections. Epidemiol Infect (2011) 0.92
Cytotoxicity of latex urinary catheters. Br J Urol (1985) 0.92
Polymorphism of the eosinophil cationic protein-gene is related to the expression of allergic symptoms. Clin Exp Allergy (2002) 0.92
Experiences with the clinical and experimental use of Urat-I lithotriptor. Scand J Urol Nephrol (1972) 0.92
Volvulus of the caecum. An analysis of 40 cases and the value of various surgical measures. Acta Chir Scand (1972) 0.90
Mast cells in interstitial cystitis. Br J Urol (1982) 0.90
Cyclosporine in severe interstitial cystitis. J Urol (1996) 0.89
Bladder function in urologically normal middle aged females. A urodynamic and radiological investigation. Scand J Urol Nephrol (1979) 0.89
Extraperitoneal pelvioscopy: a new aid in staging of lower urinary tract tumors. A preliminary report. J Urol (1980) 0.89
Validation of the self-administered Danish Prostatic Symptom Score (DAN-PSS-1) system for use in benign prostatic hyperplasia. Br J Urol (1995) 0.89
Preoperative irradiation in the treatment of renal adenocarcinoma. Scand J Urol Nephrol (1977) 0.88
Effect of preoperative radiotherapy on the growth of human renal carcinoma tissue in vitro. Scand J Urol Nephrol (1973) 0.88
Prostaglandin type E activity dominates in urinary tract smooth muscle in vitro. J Urol (1983) 0.87
A new patient weighted symptom score system (DAN-PSS-1). Clinical assessment of indications and outcomes of transurethral prostatectomy for uncomplicated benign prostatic hyperplasia. Scand J Urol Nephrol (1993) 0.87
Clinical evaluation of transurethral versus transvesical prostatectomy. A randomized study. Scand J Urol Nephrol (1984) 0.87
Control of life-threatening vesical hemorrhage by unilateral hypogastric artery muscle embolization. J Urol (1974) 0.86
Cytostatic effect of different strains of Bacillus Calmette-Guérin on human bladder cancer cells in vitro alone and in combination with mitomycin C and interferon-alpha. Urol Res (1992) 0.86
Reproducibility and reliability of urinary incontinence assessment with a 60 min test. Scand J Urol Nephrol (1984) 0.86
Induratio penis plastica (Peyronie's disease). Cavernosography in assessment of the disease process. Scand J Urol Nephrol (1974) 0.85
Bladder function in healthy elderly males. Scand J Urol Nephrol (1978) 0.85
[Comparison of thin-needle and Vim-Silverman-needle biopsy in the diagnosis of prostatic cancer]. Duodecim (1968) 0.83
Torsion of the testis diagnosed by ultrasound. J Urol (1975) 0.83
Treatment with azlocillin in complicated urinary tract infections. Arzneimittelforschung (1979) 0.83
Clinical experience with a radio-linked bladder stimulator. J Urol (1967) 0.83
Percutaneous cytological aspiration biopsy in the diagnosis of renal tumours. Ann Chir Gynaecol Fenn (1969) 0.82
Tissue antibodies in malignant and benign urogenital disease. Int J Cancer (1977) 0.82
Bladder denervation procedures. Urol Clin North Am (1979) 0.82
Treatment of urethral stricture by urethroplasty or direct vision urethrotomy. A comparative retrospective study. Scand J Urol Nephrol (1983) 0.82
Towards an integrated approach in supporting microbiological food safety decisions. Zoonoses Public Health (2007) 0.82
Orchiectomy versus oestrogen in the treatment of advanced prostatic cancer. Br J Urol (1991) 0.82
The effect of parenteral estrogen versus orchiectomy on blood coagulation and fibrinolysis in prostatic cancer patients. Eur Urol (1990) 0.82
Symptom scores in benign prostatic hyperplasia. Urology (1997) 0.81
Electron microscopic investigation of the bladder urothelium and glycocalyx in patients with interstitial cystitis. J Urol (1986) 0.81
Standardized evaluation of erectile dysfunction in 95 consecutive patients. J Urol (1989) 0.81
Intravesical chemotherapy (mitomycin C) versus immunotherapy (bacillus Calmette-Guérin) in superficial bladder cancer. Eur Urol (1991) 0.81
Localized sarcoidosis of the appendix simulating Mb crohn. Report of a case. Acta Chir Scand (1968) 0.81
Detrusor in ageing and obstruction. Scand J Urol Nephrol (1995) 0.81
The cysteinyl leukotriene D4 receptor antagonist montelukast for the treatment of interstitial cystitis. J Urol (2001) 0.81
Recombinant interleukin-2 and lymphokine-activated killer cell treatment of advanced bladder cancer: clinical results and immunological effects. Cancer Res (1992) 0.81
The effect of roentgen ray treatment of gynecomastia in patients with prostatic carcinoma treated with estrogenic hormones: a preliminary communication. J Urol (1965) 0.81
Pathogenesis of nocturnal urinary incontinence after ileocaecal bladder replacement. Continuous measurement of urethral closure pressure during sleep. Br J Urol (1987) 0.80
Intralesional corticosteroid injections in combination with internal urethrotomy in the treatment of urethral strictures. Int Urol Nephrol (1990) 0.80
Comparison of the Danish Prostatic Symptom Score with the International Prostatic Symptom Score, the Madsen-Iversen and Boyarsky symptom indexes. ALFECH Study Group. Br J Urol (1998) 0.80
Are doctors able to assess prostatic size? Scand J Urol Nephrol (1978) 0.80
Ultrasonic method of measuring residual urine. Ann Chir Gynaecol Fenn (1969) 0.80
Accuracy in preoperative estimation of prostatic size. A comparative evaluation of rectal palpation, intravenous pyelography, urethral closure pressure profile recording and cystourethroscopy. Scand J Urol Nephrol (1981) 0.80
Oncogenes in human testicular cancer: DNA and RNA studies. Br J Cancer (1991) 0.80
Suprapubic cystostomy catheterization in open-heart surgery. Scand J Thorac Cardiovasc Surg (1984) 0.80
Silent iliac compression syndrome as a cause of renal vein thrombosis after transplantation. Scand J Urol Nephrol (1972) 0.80
Alternating mitomycin C and bacillus Calmette-Guerin instillation therapy for carcinoma in situ of the bladder. The Finnbladder Group. J Urol (1995) 0.80
Instillation of mitomycin C and doxorubicin in the prevention of recurrent superficial (Ta-T1) bladder cancer. Br J Urol (1987) 0.79
Hormone-resistant metastatic prostate cancer. Comparisons between estramustine phosphate and low-dose epirubicin treatments. Eur Urol (1991) 0.79
Bladder training and terodiline in females with idiopathic urge incontinence and stable detrusor function. Scand J Urol Nephrol (1986) 0.79
Treatment of Condyloma acuminata in male patients. Eur Urol (1977) 0.79
Vasoactive intestinal polypeptide influence on lower urinary tract smooth muscle from human and pig. J Urol (1984) 0.79
Concentration of gentamicin in serum, urine and urogenital tissue in man. Acta Pathol Microbiol Scand B Microbiol Immunol (1973) 0.79
Eosinophil cationic protein (ECP). Int J Biochem Cell Biol (1998) 0.79
Induratio penis plastica Peyronie's disease. Clinical features and etiology. Scand J Urol Nephrol (1976) 0.79
Characterization of the divergent eosinophil ribonuclease, mEar 6, and its expression in response to Schistosoma mansoni infection in vivo. Genes Immun (2004) 0.79
Adriamycin instillations as recurrence prophylaxis in superficial urinary bladder cancer. Ann Chir Gynaecol (1984) 0.79
Urodynamic evaluation after vaginal repair and colposuspension. Br J Urol (1982) 0.78
A bioresorbable urethral stent. An experimental study. Urol Res (1993) 0.78
Increased intraprostatic pressure in patients with chronic prostatitis. Urol Res (1999) 0.78
The action of cysteinyl-leukotrienes on intracellular calcium mobilization in human detrusor myocytes. BJU Int (2001) 0.78
Pretreatment plasma levels of testosterone and sex hormone binding globulin binding capacity in relation to clinical staging and survival in prostatic cancer patients. Prostate (1988) 0.78
Idiopathic perforation of the colon in infancy. Acta Chir Scand (1968) 0.78
Incontinence surgery in female motor urge incontinence. Acta Obstet Gynecol Scand (1983) 0.78
Studies in stimulation of the bladder and its motor nerves. Surgery (1966) 0.78
The effects, costs and benefits of Salmonella control in the Danish table-egg sector. Epidemiol Infect (2008) 0.78
Tigason (etretinate) in prevention of recurrence of superficial bladder tumors. A double-blind clinical trial. Eur Urol (1983) 0.78
Unprocessed bran and intermittent thiazide therapy in prevention of recurrent urinary calcium stones. Scand J Urol Nephrol (1987) 0.78
Polyamines and other accessory sex gland secretions in human seminal plasma 8 years after vasectomy. J Reprod Fertil (1989) 0.77
Evoked potentials from the lower urinary tract. II. The spino-cortical neuraxis. A methodological study. Scand J Urol Nephrol Suppl (1991) 0.77